Disease · MONDO_0002465
Comparisons in its trials23
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 23
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Nebulized 3% Saline vs Nebulized 0.9% Saline: Number of Participants With Supplemental Medication Use | 39 of 231 | 39 of 216 | 447 | NCT00619918 | Trial comparisons |
| Hypertonic Saline vs Normal Saline: deaths from any cause | 0 of 231 | 0 of 216 | 447 | NCT00619918 | Trial comparisons |
| Hypertonic Saline vs Normal Saline: serious adverse events | 0 of 231 | 0 of 216 | 447 | NCT00619918 | Trial comparisons |
| Hypertonic Saline vs Normal Saline: Clinical Worsening | 10 of 113 | 9 of 114 | 227 | NCT01488448 | Trial comparisons |
| Hypertonic Saline vs Normal Saline: serious adverse events | 13 of 113 | 10 of 114 | 227 | NCT01488448 | Trial comparisons |
| Nebulized Hypertonic Saline vs Nebulized Normal Saline: Readmission for Bronchiolitis Within 7 Days of Discharge | 4 of 93 | 3 of 97 | 190 | NCT01488448 | Trial comparisons |
| Montelukast vs Placebo: serious adverse events | 0 of 68 | 0 of 73 | 141 | NCT00863317 | Trial comparisons |
| Hypertonic vs Normal: serious adverse events | 0 of 50 | 0 of 50 | 100 | NCT01238848 | Trial comparisons |
| Heliox vs Oxygen: deaths from any cause | 0 of 34 | 0 of 35 | 69 | NCT00116584 | Trial comparisons |
| Heliox vs Oxygen: serious adverse events | 0 of 34 | 0 of 35 | 69 | NCT00116584 | Trial comparisons |
| 3% Hypertonic Saline Group vs 0.9% Normal Saline Group: Rate of Hospitalizations | 9 of 25 | 11 of 27 | 52 | NCT02029040 | Trial comparisons |
| 3% Hypertonic Saline Group vs 0.9% Normal Saline Group: deaths from any cause | 0 of 25 | 0 of 27 | 52 | NCT02029040 | Trial comparisons |
| 3% Hypertonic Saline Group vs 0.9% Normal Saline Group: serious adverse events | 0 of 25 | 0 of 27 | 52 | NCT02029040 | Trial comparisons |
| Single Dose of Furosemide vs Placebo: Patient Needing Endotracheal Intubation | 0 of 22 | 0 of 24 | 46 | NCT02469597 | Trial comparisons |
| Single Dose of Furosemide vs Placebo: serious adverse events | 0 of 22 | 0 of 24 | 46 | NCT02469597 | Trial comparisons |
| Hypertonic Saline vs No Treatment: Unscheduled Return ED Visits | 0 of 9 | 0 of 9 | 18 | NCT02834819 | Trial comparisons |
| Hypertonic Saline vs No Treatment: Adverse Outcomes | 0 of 9 | 0 of 9 | 18 | NCT02834819 | Trial comparisons |
| Hypertonic Saline vs No Treatment: Hospitalization Rate | 2 of 9 | 1 of 9 | 18 | NCT02834819 | Trial comparisons |
| Hypertonic Saline vs No Treatment: Need for Supplemental Oxygen After Discharge | 9 of 9 | 9 of 9 | 18 | NCT02834819 | Trial comparisons |
| Hypertonic Saline vs No Treatment: Number of Patients With Persistent Hypoxia | 9 of 9 | 9 of 9 | 18 | NCT02834819 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0002465/comparisons